SANDOZ PIRFENIDONE CAPSULES

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 83ab7ea9b6447c1e
Drug Approval Canada Name: SANDOZ PIRFENIDONE CAPSULES
Product Name: SANDOZ PIRFENIDONE CAPSULES
Status: Marketed
Status Date: 2021-10-25
Original Market Date: 2021-10-25
Din: 02488833
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 48:02.00
Atc Original: L04AX05 PIRFENIDONE
Atc Name: l 04 ax 05
Aig Number: 0153328001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

PIRFENIDONE

267 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

83ab7ea9b6447c1e

Type

Standard